rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2001-3-20
|
pubmed:abstractText |
Icodextrin is proposed as a new osmotic agent for use in peritoneal dialysis. Because of its recent use, adverse reactions are not well known. Cutaneous adverse effects have been described. We report 3 cases of cutaneous hypersensitivity to icodextrin and discuss the pathogenesis of this reaction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-987X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
137
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
309-10
|
pubmed:dateRevised |
2008-3-17
|
pubmed:meshHeading |
pubmed-meshheading:11255330-Dialysis Solutions,
pubmed-meshheading:11255330-Drug Eruptions,
pubmed-meshheading:11255330-Female,
pubmed-meshheading:11255330-Glucans,
pubmed-meshheading:11255330-Glucose,
pubmed-meshheading:11255330-Humans,
pubmed-meshheading:11255330-Male,
pubmed-meshheading:11255330-Middle Aged,
pubmed-meshheading:11255330-Peritoneal Dialysis,
pubmed-meshheading:11255330-Psoriasis,
pubmed-meshheading:11255330-Skin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Icodextrin cutaneous hypersensitivity: report of 3 psoriasiform cases.
|
pubmed:affiliation |
Department of Dermatology, Hôpital Bichat-Claude Bernard, Assistance Publique-Hopitaux de Paris, France.
|
pubmed:publicationType |
Journal Article,
Case Reports
|